These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23663349)

  • 1. Design, synthesis, and evaluation of indolebutylamines as a novel class of selective dopamine D3 receptor ligands.
    Du P; Xu L; Huang J; Yu K; Zhao R; Gao B; Jiang H; Zhao W; Zhen X; Fu W
    Chem Biol Drug Des; 2013 Sep; 82(3):326-35. PubMed ID: 23663349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interactive SAR approach to discover novel hybrid thieno probes as ligands for D2-like receptors with affinities in the subnanomolar range.
    Abdel-Fattah MA; Lehmann J; Abadi AH
    Chem Biodivers; 2013 Dec; 10(12):2247-66. PubMed ID: 24327445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.
    Ji M; Chen J; Ding K; Wu X; Varady J; Levant B; Wang S
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1701-5. PubMed ID: 15745825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrazides of clozapine: a new class of D1 dopamine receptor subtype selective antagonists.
    Sasikumar TK; Burnett DA; Zhang H; Smith-Torhan A; Fawzi A; Lachowicz JE
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4543-7. PubMed ID: 16809034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.
    Campiani G; Butini S; Trotta F; Fattorusso C; Catalanotti B; Aiello F; Gemma S; Nacci V; Novellino E; Stark JA; Cagnotto A; Fumagalli E; Carnovali F; Cervo L; Mennini T
    J Med Chem; 2003 Aug; 46(18):3822-39. PubMed ID: 12930145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D(3) receptor ligands.
    Insua I; Alvarado M; Masaguer CF; Iglesias A; Brea J; Loza MI; Carro L
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5586-91. PubMed ID: 24012118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.
    Madapa S; Gadhiya S; Kurtzman T; Alberts IL; Ramsey S; Reith M; Harding WW
    Eur J Med Chem; 2017 Jan; 125():255-268. PubMed ID: 27688181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of structurally constrained hybrid analogues containing ropinirole moiety as a novel class of potent and selective dopamine D3 receptor ligands.
    Zhou B; Hong KH; Ji M; Cai J
    Chem Biol Drug Des; 2018 Sep; 92(3):1597-1609. PubMed ID: 29710404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and discovery of 1,3-benzodiazepines as novel dopamine antagonists.
    Zhu Z; Sun ZY; Ye Y; McKittrick B; Greenlee W; Czarniecki M; Fawzi A; Zhang H; Lachowicz JE
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5218-21. PubMed ID: 19643610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
    Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
    J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor.
    Austin NE; Avenell KY; Boyfield I; Branch CL; Hadley MS; Jeffrey P; Johnson CN; Macdonald GJ; Nash DJ; Riley GJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Wood MD
    Bioorg Med Chem Lett; 2001 Mar; 11(5):685-8. PubMed ID: 11266169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further SAR study on 11-O-substituted aporphine analogues: identification of highly potent dopamine D3 receptor ligands.
    Ye N; Wu Q; Zhu L; Zheng L; Gao B; Zhen X; Zhang A
    Bioorg Med Chem; 2011 Mar; 19(6):1999-2008. PubMed ID: 21334902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands.
    Huang Y; Luedtke RR; Freeman RA; Wu L; Mach RH
    J Med Chem; 2001 May; 44(11):1815-26. PubMed ID: 11356115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
    Cao Y; Paudel S; Zhang X; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Sep; 23(17):5264-72. PubMed ID: 26278029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
    Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
    J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.
    Ananthan S; Saini SK; Zhou G; Hobrath JV; Padmalayam I; Zhai L; Bostwick JR; Antonio T; Reith ME; McDowell S; Cho E; McAleer L; Taylor M; Luedtke RR
    J Med Chem; 2014 Aug; 57(16):7042-60. PubMed ID: 25126833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands.
    Li A; Mishra Y; Malik M; Wang Q; Li S; Taylor M; Reichert DE; Luedtke RR; Mach RH
    Bioorg Med Chem; 2013 Jun; 21(11):2988-98. PubMed ID: 23618707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.